Gilead Sciences (GILD) PT Raised to $123 at RBC Capital

August 5, 2026 7:48 AM

RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $123.00 (from $120.00) while maintaining a Sector Perform rating.

No results found